Clinton Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,576
| Closed | -$257K | – | 480 |
|
|
2018
Q1 | $257K | Sell |
1,576
-36,964
| -96% | -$6.03M | 0.03% | 319 |
|
|
2017
Q4 | $5.78M | Buy |
38,540
+34,995
| +987% | +$5.24M | 0.51% | 57 |
|
|
2017
Q3 | $539K | Buy |
+3,545
| New | +$539K | 0.06% | 281 |
|
|
2017
Q2 | – | Sell |
-11,000
| Closed | -$1.2M | – | 887 |
|
|
2017
Q1 | $1.2M | Buy |
+11,000
| New | +$1.2M | 0.07% | 385 |
|
|
2016
Q4 | – | Sell |
-6,461
| Closed | -$563K | – | 1028 |
|
|
2016
Q3 | $563K | Buy |
+6,461
| New | +$563K | 0.03% | 645 |
|